Moderna raises 2021 sales forecast for Covid-19 vaccine to $19.2 bln
Larger rival Pfizer Inc had said it expects $26 billion in sales of its Covid-19 vaccine this year
Moderna Inc raised its 2021 sales forecast for its Covid-19 vaccine by 4.3% to $19.2 billion on Thursday, reflecting demand from countries looking to return to normalcy through rapid inoculation.
Larger rival Pfizer Inc had said it expects $26 billion in sales of its Covid-19 vaccine this year.